查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1995383

数位PCR和即时PCR市场：按产品类型、技术、应用和最终用户划分－2026-2032年全球市场预测

Digital PCR & Real-Time PCR Market by Product Type, Technology, Application, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，数位 PCR 和即时PCR市场价值将达到 107.8 亿美元，到 2026 年将成长到 121.2 亿美元，到 2032 年将达到 252 亿美元，复合年增长率为 12.88%。

主要市场统计数据
基准年 2025 107.8亿美元
预计年份：2026年 121.2亿美元
预测年份 2032 252亿美元
复合年增长率 (%) 12.88%

全面概述数位 PCR 和即时PCR的创新如何重新定义临床检测、研究工作流程和营运重点。

数位PCR和即时PCR的融合正在加速分子分析进入新时代。在这个时代，灵敏度、准确性和处理能力是决定检查室效能和临床应用的关键因素。即时PCR已成为核酸定量检测的标准，并且仍然是高通量诊断流程和符合监管要求的检测中不可或缺的工具。同时，数位PCR作为一种互补技术正在兴起，它能够提供绝对定量，并对低表达标靶具有卓越的性能，从而实现从微量残存疾病监测到精确拷贝数变异分析等广泛的应用。这两种平台的结合正在重新定义诊断、环境监测、食品安全检测和前沿研究应用中的数据可靠性。

对正在重塑分子诊断生态系统的技术采用、工作流程整合和价值链预期的关键变革性变化进行详细分析。

分子诊断领域正经历一场变革，其驱动力来自于技术的成熟、工作流程的整合以及终端使用者需求的不断变化。随着供应商不断提升通量、自动化和数据分析能力，降低了常规检查室应用的门槛，数位PCR平台正从特定应用领域走向更广泛的应用。同时，即时PCR系统也不断发展，具备更快的热循环速度、多重处理能力以及更完善的软体生态系统，从而简化了检测方法的开发和法规遵循。这种双管齐下的演进正在催生一种混合检查室筛检：利用即时PCR进行高通量筛选，而利用数位PCR进行确认性检测以及对灵敏度要求较高的应用场景。

对 2025 年美国实施的关税调整的累积营运和战略影响以及对供应链的连锁反应进行严格评估。

美国将于2025年实施的新关税措施，给分子诊断供应链中的製造商、经销商和检查室负责人带来了一系列复杂的营运压力。进口关税的提高和海关检查的严格程度，增加了从海外采购设备、试剂和特殊耗材的成本，迫使采购团队重新评估其供应商关係和库存策略。为此，一些供应商正在加快生产本地化进程，并扩大关键试剂的国内采购，以维持价格竞争力并保护自身业务免受进一步关税变化的影响。

详细的細項分析揭示了产品类型、技术形式、检体矩阵、应用领域和最终用户概况如何影响商业性和技术重点。

细分市场洞察揭示了产品类型、技术、样本类型、应用和最终用户等各个层面微妙的需求驱动因素，从而影响研发重点和商业化策略。按产品类型划分，仪器因其自动化和通量提升而持续受到关注，而酵素、预混液、探针和引子等试剂和耗材仍是维持收入、决定长期盈利的基础。服务和软体越来越多地作为增值要素提供，以增强客户关係。依技术划分，市场动态的特征是数位PCR和即时PCR并存。晶片型和液滴型数位PCR技术在灵敏度和样本处理能力方面展开竞争，而定量即时PCR和逆转录即时PCR则满足了基因表现检测和诊断检测的广泛需求。

全面深入的区域分析，阐述美洲、欧洲、中东和非洲以及亚太地区的趋势如何影响采用、监管和商业性方法。

区域趋势正以不同的方式影响着各主要地区的技术应用、监管路径和商业策略。在美洲，临床检查室的整合、支付方趋势以及对精准诊断的高度重视是推动需求成长的主要因素，这刺激了对能够提供临床级数据且具备可扩展处理能力的平台进行投资。在北美市场，快速检测检验以及与电子健康记录 (EHR) 系统的整合也促使供应商优先考虑那些能够提供完善文件和互通性的供应商。在拉丁美洲，日益增长的公共卫生监测需求促使人们更加关注经济高效的试剂供应和培训项目，以扩大分子检测的覆盖范围。

深入了解企业策略行动和竞争考察，揭示技术蓝图、伙伴关係和服务模式如何塑造供应商差异化。

分子诊断产业的企业策略体现了技术差异化、商业性覆盖范围和生命週期支援之间的平衡。领先的仪器製造商透过扩展已部署仪器的服务范围来增加经常性收入，同时优先开发能够实现即时平台和数位平台之间无缝检测迁移的系统。试剂供应商则专注于检测标准化和跨多个仪器生态系统的兼容性，以降低客户门槛并培养品牌忠诚度。软体和分析服务提供者正在不断完善其平台，提供基于云端的数据管理、先进的曲线拟合演算法以及符合合规要求的审计追踪，以满足检查室效率和监管报告的需求。

为行业领导者提供切实可行的建议，以透过产品、供应链和服务方面的创新来增强韧性、加快采用速度并优化经营模式。

行业领导者可以在诊断和研究市场采取切实有效的措施，以增强市场韧性、加速产品普及并抓住成长机会。首先，他们应优先考虑模组化产品架构和检验的试剂生态系统，使客户能够从概念验证(PoC) 阶段扩展到常规检测，而不会对其工作流程造成重大干扰。这种方法可以减少采购摩擦，并有助于延长客户生命週期。其次，他们应投资于区域性製造地和多元化的供应商网络，以降低关税风险，并确保关键试剂和耗材的持续供应，从而提高价格可预测性和客户信心。

这种透明的调查方法详细介绍了基于访谈的见解、文献整合和检验程序，为决策者产生可操作的见解。

本分析的调查方法透过整合证据、专家验证和跨职能检验，确保了其可靠性和有效性。关键资讯来源包括对实验室经理、采购负责人和研发经理的结构化检验，这些访谈提供了关于技术选择标准、工作流程限制和供应商绩效的第一手观点。此外，我们也系统性地回顾了技术文献、法规指南、产品规格以及近期发表的同行评审研究，这些文献描述了数位PCR和即时PCR平台的分析性能特征和应用成果。

结论强调了数位 PCR 和即时PCR的互补作用，以及实现永续部署和影响所需的策略重点。

总而言之，数位PCR和即时PCR技术的融合正在为诊断、环境监测、食品安全、法医学和前沿调查等领域打造一套多功能工具包。实验室机构正日益采用混合策略，将即时PCR的处理能力和监管成熟度与数位PCR的灵敏度和绝对定量能力结合。同时，2025年的关税环境凸显了供应链多元化、区域化生产和一体化服务交付的重要性，以保障利润率并防止侦测能力中断。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：数位PCR和即时PCR市场：按产品类型划分

  • 装置
  • 试剂和耗材
    • 酵素
    • 母带混音
    • 探针和引子
  • 服务
  • 软体

第九章：数位PCR和即时PCR市场：按技术划分

  • 数位PCR
    • 晶片式数位PCR
    • 液滴式数位PCR
  • 即时PCR
    • 定量即时PCR（qPCR）
    • 即时PCR（RT-qPCR）

第十章：数位PCR和即时PCR市场：按应用划分

  • 临床应用
    • 传染病检查
    • 肿瘤科检查
    • 移植诊断
  • 环境应用
  • 食品安全
    • 过敏原检测
    • 病原体检测
  • 法医学应用
  • 出于研究目的
    • 基因表现
    • 单细胞分析
    • 干细胞研究

第十一章 数位PCR和即时PCR市场：按最终用户划分

  • 学术和研究机构
  • 临床诊断检查室
  • 法医学研究所
  • 製药和生物技术公司

第十二章 数位PCR和即时PCR市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：数位PCR和即时PCR市场：按类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 数位PCR和即时PCR市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国数位PCR与即时PCR市场

第十六章：中国数位PCR与即时PCR市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena GmbH+Co. KG
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biocompare
  • BIOMERIEUX SA
  • Bioneer Corporation
  • Danaher Corporation
  • ELITech Group by Bruker Corp
  • Enzo Life Sciences, Inc.
  • Eppendorf SE
  • Etcon Analytical and Environmental Systems & Services Ltd.
  • Explorea sro
  • F. Hoffmann-La Roche Ltd.
  • Hangzhou Longgene Scientific Instruments Co., Ltd.
  • Heal Force Bio-Meditech Holdings Limited
  • LABGENE Scientific SA
  • Merck KGaA
  • Promega Corporation
  • QIAGEN NV
  • Quidel Corporation
  • R-Biopharm AG
  • RainSure Scientific
  • SD Biosensor, Inc.
  • Solis BioDyne OU
  • STANDARD BIOTOOLS INC.
  • Takara Bio USA, Inc.
  • Thermo Fisher Scientific Inc.
  • Zymo Research Corp.
Product Code: MRR-8760467AA4C1

The Digital PCR & Real-Time PCR Market was valued at USD 10.78 billion in 2025 and is projected to grow to USD 12.12 billion in 2026, with a CAGR of 12.88%, reaching USD 25.20 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 10.78 billion
Estimated Year [2026] USD 12.12 billion
Forecast Year [2032] USD 25.20 billion
CAGR (%) 12.88%

Comprehensive introduction to how digital PCR and real-time PCR innovations are redefining laboratory diagnostics, research workflows, and operational priorities

The convergence of digital PCR and real-time PCR has accelerated a new era in molecular analysis, where sensitivity, precision, and throughput are key determinants of laboratory performance and clinical impact. Real-time PCR established a baseline for quantitative nucleic acid detection and remains indispensable for high-throughput diagnostic workflows and regulatory-compliant testing. Meanwhile, digital PCR has emerged as a complementary technology that delivers absolute quantification and superior performance for low-abundance targets, enabling applications from minimal residual disease monitoring to precise copy number variation analysis. Together, these platforms are redefining data reliability in diagnostics, environmental surveillance, food safety testing, and advanced research applications.

As stakeholders evaluate technology adoption, several practical considerations shape procurement and implementation choices. Instrument footprint, sample-to-answer turnaround time, ease of assay migration, integration with laboratory information systems, and the availability of reagents and consumables are all critical. In addition, evolving regulatory expectations and the need for robust validation data drive demand for standardized workflows and certified reagents. Transition decisions are increasingly strategic rather than tactical, with laboratories balancing operational efficiency against the clinical or scientific value delivered by higher-resolution quantification.

Detailed analysis of major transformative shifts in technology adoption, workflow integration, and value chain expectations reshaping the molecular diagnostics ecosystem

The molecular diagnostics landscape is undergoing transformative shifts driven by technological maturation, workflow consolidation, and shifting end-user expectations. Digital PCR platforms have moved beyond niche use to broader adoption as vendors refine throughput, automation, and data analysis capabilities, reducing the friction for routine laboratory deployment. Concurrently, real-time PCR systems continue to evolve with faster thermocycling, multiplexing capacity, and enhanced software ecosystems that simplify assay development and regulatory compliance. This dual-track evolution is encouraging hybrid laboratory strategies, where teams deploy real-time PCR for high-throughput screening and digital PCR for confirmatory or high-sensitivity use cases.

Another major shift is the demand for integrated solutions that combine instrumentation, validated reagents, software analytics, and service agreements. Customers now expect vendors to deliver end-to-end value, including simplified assay transfer, remote troubleshooting, and lifecycle management. In parallel, greater emphasis on decentralized testing and near-patient diagnostics is prompting compact, robust instrument formats and simplified user interfaces. Data integrity and cybersecurity are also rising priorities as laboratory networks expand and results drive clinical decision-making, increasing the need for interoperable data systems and audit-ready software functionality.

Rigorous assessment of the cumulative operational and strategic effects resulting from United States tariff adjustments implemented during 2025 and their implications for supply chains

The introduction of new tariff measures by the United States in 2025 has created a complex set of operational pressures for manufacturers, distributors, and laboratory purchasers within the molecular diagnostics supply chain. Increased import duties and broader customs scrutiny have elevated landed costs for instruments, reagents, and specialty consumables sourced internationally, driving procurement teams to reassess supplier relationships and inventory strategies. In response, some vendors have accelerated localization of manufacturing and broadened domestic sourcing for critical reagents to maintain competitive pricing and shield operations from further tariff volatility.

In addition to cost pressures, tariffs have incentivized strategic inventory buffering and longer-term supply agreements to smooth procurement cycles and protect clinical and research continuity. Distributors and end-users are negotiating multi-year pricing frameworks and consignment models to stabilize supply lines. These adjustments have immediate operational implications, including increased working capital requirements for inventory and altered procurement lead times. Over the medium term, the tariff environment is likely to catalyze a redistribution of manufacturing footprints and a renewed focus on supply chain resilience as a key dimension of strategic planning.

In-depth segmentation analysis illuminating how product type, technological format, sample matrix, application area, and end-user profile drive commercial and technical priorities

Segmentation insights reveal nuanced demand drivers across product types, technologies, sample types, applications, and end users that are shaping development priorities and commercialization strategies. Based on product type, instruments continue to command attention for automation and throughput improvements while reagents and consumables such as enzymes, master mixes, and probes and primers remain the recurring revenue backbone that determines long-term profitability; services and software are increasingly offered as value-added components to lock in customer relationships. Based on technology, the market dynamic is defined by the coexistence of digital PCR and real-time PCR, where chip-based and droplet digital PCR formats compete on sensitivity and sample throughput, and where quantitative real-time PCR and reverse transcription real-time PCR sustain broad demand for gene expression and diagnostic assays.

Based on sample type, blood samples including plasma and serum are central to clinical diagnostics and biomarker applications, while environmental samples such as soil and water demand ruggedized workflows for field and surveillance testing; food samples and tissue samples present distinct extraction and assay validation needs that influence reagent formulations and QC processes. Based on application, clinical applications encompass infectious disease testing, oncology testing, and transplant diagnostics, while environmental applications, food safety with allergen and pathogen testing, forensic applications, and research applications such as gene expression, single cell analysis, and stem cell research each have bespoke performance and validation requirements. Based on end user, academic and research institutes emphasize innovation and method development, clinical diagnostics laboratories prioritize throughput and regulatory compliance, forensic labs require chain-of-custody assurance and validation rigor, and pharmaceutical and biotechnology companies seek scalable platforms for both discovery and regulated workflows. Together these segmentation lenses inform product design, pricing strategies, go-to-market planning, and service offerings across the industry.

Comprehensive regional insights describing how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence adoption, regulation, and commercial approaches

Regional dynamics are shaping technology adoption, regulatory pathways, and commercial strategies in distinctive ways across core geographies. In the Americas, demand is heavily influenced by clinical laboratory consolidation, payer dynamics, and a strong emphasis on precision diagnostics, driving investment in platforms that deliver clinical-grade data with scalable throughput. North American markets also prioritize rapid assay validation and integration with electronic health record systems, which favors vendors that provide robust documentation and interoperability. Latin American territories exhibit growing public health surveillance needs and are increasingly focused on cost-effective reagent supply and training programs to expand molecular testing access.

In Europe, Middle East & Africa, diverse regulatory frameworks and variable laboratory infrastructures create a mosaic of adoption patterns that require localized regulatory support and flexible service models. Western Europe tends to adopt advanced technologies rapidly due to strong research ecosystems and established clinical networks, whereas parts of the Middle East and Africa emphasize capacity building and partnerships for sustainable testing programs. In the Asia-Pacific region, high-volume testing needs, strong manufacturing capabilities, and rapid commercialization cycles encourage intense competition and fast iteration on instrument features. Several markets in Asia-Pacific are simultaneously scaling decentralized testing and investing in centralized reference laboratories, which opens pathways for both compact point-of-care formats and high-throughput real-time PCR systems.

Strategic company behaviors and competitive positioning insights revealing how technology roadmaps, partnerships, and service models are shaping vendor differentiation

Company strategies across the molecular diagnostics landscape reflect a balance between technological differentiation, commercial reach, and lifecycle support. Leading instrument manufacturers are prioritizing systems that enable seamless assay transfer between real-time and digital platforms, while expanding installed-base service offerings to increase recurring revenue. Reagent suppliers are emphasizing assay standardization and compatibility with multiple instrument ecosystems to lower barriers for customers and to foster brand loyalty. Software and analytics providers are maturing their platforms to provide cloud-enabled data management, advanced curve-fitting algorithms, and compliance-ready audit trails that address both laboratory efficiency and regulatory reporting needs.

Strategic partnerships, targeted acquisitions, and collaborative development agreements are also prominent as companies seek to offer bundled solutions and accelerate time to market for validated assays. Companies that offer comprehensive training programs, strong technical support, and accessible validation resources gain competitive advantage in health systems and research institutions that require rapid adoption with minimal disruption. Finally, firms that invest in regional manufacturing and robust supply chain networks are better positioned to mitigate tariff exposure and to respond to local procurement preferences, creating differentiated value propositions in price-sensitive markets.

Actionable recommendations for industry leaders to enhance resilience, accelerate adoption, and optimize commercial models through product, supply chain, and service innovation

Industry leaders can take pragmatic, high-impact actions to strengthen resilience, accelerate adoption, and capture growth opportunities across diagnostic and research markets. First, prioritize modular product architectures and validated reagent ecosystems that enable customers to scale from proof-of-concept to routine testing without major workflow disruption. This approach reduces friction during procurement and supports longer customer lifecycles. Second, invest in regional manufacturing and diversified supplier networks to mitigate tariff exposure and to ensure continuity of critical reagent and consumable supply, thereby improving price predictability and customer trust.

Third, develop comprehensive service and support packages that include remote diagnostics, training, and co-validation programs to lower the operational burden on customers. Fourth, expand software capabilities that ensure data integrity, interoperability with laboratory information systems, and streamlined regulatory documentation to meet the needs of clinical laboratories. Finally, pursue targeted partnerships with clinical institutions, public health agencies, and research centers to co-develop high-value assays and to demonstrate real-world clinical utility, thereby accelerating uptake and building robust evidence for reimbursement and institutional adoption.

Transparent research methodology detailing interview-driven insights, literature synthesis, and validation steps used to produce actionable intelligence for decision-makers

The research methodology underpinning this analysis combines evidence synthesis, expert validation, and cross-functional triangulation to ensure credibility and relevance. Primary inputs included structured interviews with laboratory leaders, procurement officers, and R&D directors who provided firsthand perspectives on technology selection criteria, workflow constraints, and vendor performance. These qualitative insights were complemented by a systematic review of technical literature, regulatory guidance, product specifications, and recent peer-reviewed studies that document analytical performance characteristics and application outcomes for both digital PCR and real-time PCR platforms.

To ensure robustness, findings were cross-checked with vendor technical documentation and publicly available clinical validation studies. Supply chain and tariff impact assessments were informed by trade policy announcements, import/export trends, and stakeholder interviews with procurement specialists and distribution partners. Throughout the process, key assumptions and illustrative scenarios were validated with subject matter experts to reflect practical implementation realities and to identify critical uncertainties that warrant close monitoring by decision-makers.

Concluding synthesis emphasizing the complementary roles of digital PCR and real-time PCR and the strategic priorities required for sustainable adoption and impact

In summary, the interplay between digital PCR and real-time PCR technologies is creating a versatile toolkit for diagnostics, environmental surveillance, food safety, forensic work, and cutting-edge research. Laboratories are increasingly adopting hybrid strategies that leverage the throughput and regulatory maturity of real-time PCR alongside the sensitivity and absolute quantitation capabilities of digital PCR. At the same time, the 2025 tariff environment has underscored the importance of supply chain diversification, regional manufacturing, and integrated service offerings to protect margins and ensure uninterrupted testing capacity.

Looking ahead, success will hinge on the ability of vendors and laboratory leaders to align technical performance with operational realities, to invest in interoperable software and rigorous validation packages, and to forge collaborative models that demonstrate clinical or scientific value. By focusing on modular product design, resilient procurement strategies, and evidence-based assay development, organizations can capture the benefits of both technologies while navigating policy and market complexity.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Digital PCR & Real-Time PCR Market, by Product Type

  • 8.1. Instruments
  • 8.2. Reagents & Consumables
    • 8.2.1. Enzymes
    • 8.2.2. Master Mixes
    • 8.2.3. Probes & Primers
  • 8.3. Services
  • 8.4. Software

9. Digital PCR & Real-Time PCR Market, by Technology

  • 9.1. Digital PCR
    • 9.1.1. Chip-Based Digital PCR
    • 9.1.2. Droplet Digital PCR
  • 9.2. Real-Time PCR
    • 9.2.1. Quantitative Real-Time PCR (qPCR)
    • 9.2.2. Reverse Transcription Real-Time PCR (RT-qPCR)

10. Digital PCR & Real-Time PCR Market, by Application

  • 10.1. Clinical Applications
    • 10.1.1. Infectious Disease Testing
    • 10.1.2. Oncology Testing
    • 10.1.3. Transplant Diagnostics
  • 10.2. Environmental Applications
  • 10.3. Food Safety
    • 10.3.1. Allergen Testing
    • 10.3.2. Pathogen Testing
  • 10.4. Forensic Application
  • 10.5. Research Applications
    • 10.5.1. Gene Expression
    • 10.5.2. Single Cell Analysis
    • 10.5.3. Stem Cell Research

11. Digital PCR & Real-Time PCR Market, by End-User

  • 11.1. Academic & Research Institutes
  • 11.2. Clinical Diagnostics Laboratories
  • 11.3. Forensic Labs
  • 11.4. Pharmaceutical & Biotechnology Companies

12. Digital PCR & Real-Time PCR Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Digital PCR & Real-Time PCR Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Digital PCR & Real-Time PCR Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Digital PCR & Real-Time PCR Market

16. China Digital PCR & Real-Time PCR Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories, Inc.
  • 17.6. Agilent Technologies, Inc.
  • 17.7. Analytik Jena GmbH+Co. KG
  • 17.8. Azure Biosystems Inc.
  • 17.9. Becton, Dickinson and Company
  • 17.10. Bio-Rad Laboratories, Inc.
  • 17.11. Biocompare
  • 17.12. BIOMERIEUX S.A.
  • 17.13. Bioneer Corporation
  • 17.14. Danaher Corporation
  • 17.15. ELITech Group by Bruker Corp
  • 17.16. Enzo Life Sciences, Inc.
  • 17.17. Eppendorf SE
  • 17.18. Etcon Analytical and Environmental Systems & Services Ltd.
  • 17.19. Explorea s.r.o
  • 17.20. F. Hoffmann-La Roche Ltd.
  • 17.21. Hangzhou Longgene Scientific Instruments Co., Ltd.
  • 17.22. Heal Force Bio-Meditech Holdings Limited
  • 17.23. LABGENE Scientific SA
  • 17.24. Merck KGaA
  • 17.25. Promega Corporation
  • 17.26. QIAGEN N.V.
  • 17.27. Quidel Corporation
  • 17.28. R-Biopharm AG
  • 17.29. RainSure Scientific
  • 17.30. SD Biosensor, Inc.
  • 17.31. Solis BioDyne OU
  • 17.32. STANDARD BIOTOOLS INC.
  • 17.33. Takara Bio USA, Inc.
  • 17.34. Thermo Fisher Scientific Inc.
  • 17.35. Zymo Research Corp.

LIST OF FIGURES

  • FIGURE 1. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY MASTER MIXES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PROBES & PRIMERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CHIP-BASED DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DROPLET DIGITAL PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY QUANTITATIVE REAL-TIME PCR (QPCR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REVERSE TRANSCRIPTION REAL-TIME PCR (RT-QPCR), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ONCOLOGY TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TRANSPLANT DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ALLERGEN TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PATHOGEN TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC APPLICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GENE EXPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SINGLE CELL ANALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY STEM CELL RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL DIAGNOSTICS LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FORENSIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 203. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 206. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 208. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 209. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 211. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 212. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 213. GCC DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 236. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 239. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 241. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 242. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 243. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 244. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 246. G7 DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 247. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 248. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 250. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 251. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 252. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 253. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 255. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 257. NATO DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY DIGITAL PCR, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY REAL-TIME PCR, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY CLINICAL APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY FOOD SAFETY, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY RESEARCH APPLICATIONS, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA DIGITAL PCR & REAL-TIME PCR MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)